Oncogenes in human lung cancer

作者: Robert A. Kratzke , Eiji Shimizu , Frederic J. Kaye

DOI: 10.1007/978-1-4615-3088-6_3

关键词:

摘要: While the last 15 years have not yielded substantial improvements in diagnosis and treatment of lung cancer, this same period has experienced an extraordinary expansion our understanding cancer initiation progression. These investigations provided strong support for a multistep mechanism tumor induction progression [1,2] that previously could only be inferred from experimental animal models epidemiologic analyses. This recent work also revealed that, many cases, structural alterations gene products (for example, myc ras or p53 Rb genes) might critical steps genesis wide range adult tumors differing histologie origins. observations blur distinction investigators focusing on specific models, while at time offer hope advances any particular type will far broader implications. In addition, now genetic basis been well established, we are witnessing resurgence interest mechanisms environmental carcinogens as tools new generation prevention strategies [3]. There is currently no doubt use tobacco single most important (although only) causative factor development [4,5], these patterns abuse spread there projected worldwide increase incidence malignancies paralleling seen North America Europe over 50 years. Therefore, challenge immediate future to apply molecular clues obtained laboratory into effective preventive therapeutic applications. The purpose chapter review some more experiments concerning genetics identification (and implications) somatic mutations limited number cellular genes referred either dominant recessive oncogenes.

参考文章(157)
AM Ginsberg, M Raffeld, J Cossman, Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood. ,vol. 77, pp. 833- 840 ,(1991) , 10.1182/BLOOD.V77.4.833.833
S. Huang, N.P. Wang, B.Y. Tseng, W.H. Lee, E.H. Lee, Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. The EMBO Journal. ,vol. 9, pp. 1815- 1822 ,(1990) , 10.1002/J.1460-2075.1990.TB08306.X
Mitsudomi T, Minna Jd, Gazdar Af, Mulshine Jl, Viallet J, Linnoila Ri, Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines Oncogene. ,vol. 6, pp. 1353- 1362 ,(1991)
T Mitsudomi, S Piantadosi, M M Nau, D T Curiel, I Chiba, D L Buchhagen, H Koga, T Takahashi, D D'Amico, D Carbone, Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene. ,vol. 5, pp. 1603- 1610 ,(1990)
Bruce A. Chabner, Chien-Song Kao-Shan, Elaine C. Lee, Robert L. Fine, Jacqueline Whang-Peng, Increased Fragile Sites and Sister Chromatid Exchanges in Bone Marrow and Peripheral Blood of Young Cigarette Smokers Cancer Research. ,vol. 47, pp. 6278- 6282 ,(1987)
Kaoru Shimokata, Yoshitaka Sekido, Toyoaki Hida, Motokazu Suyama, Ryuzo Ueda, Yuichi Obata, Toshitada Takahashi, Yutaka Ariyoshi, Preferential Expression of c-kit Protooncogene Transcripts in Small Cell Lung Cancer Cancer Research. ,vol. 51, pp. 2416- 2419 ,(1991)
T.P. Mäkelä, K. Saksela, G. Evan, K. Alitalo, A fusion protein formed by L-myc and a novel gene in SCLC. The EMBO Journal. ,vol. 10, pp. 1331- 1335 ,(1991) , 10.1002/J.1460-2075.1991.TB07652.X
Alain Puisieux, John Groopman, Mehmet Ozturk, Susan Lim, Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Research. ,vol. 51, pp. 6185- 6189 ,(1991)
E R Spindel, F Cuttitta, A F Gazdar, E A Sausville, J F Battey, A M Lebacq-Verheyden, Expression of the gastrin-releasing peptide gene in human small cell lung cancer. Evidence for alternative processing resulting in three distinct mRNAs. Journal of Biological Chemistry. ,vol. 261, pp. 2451- 2457 ,(1986) , 10.1016/S0021-9258(17)35956-2